Objective: To present a review of para-aortic lymphadenectomy in gynecology. Subject: Review.
Setting: Department of Obstetrics and Gynecology, Department of Urology, Medical Faculty Hradec Králové, Charles University, Prague; Bristol-Myers Squibb, Department of Oncology, Prague. Subject and Method: Discussion about current evidence from literature and our own experience.
Conclusion: In the past 20 years, pelvic and paraaortic lymphadenectomy has become part of the standard surgical treatment of ovarian cancer. Overall, about 40% of patients with ovarian cancer will have nodal involvement.
Regarding to this real probability is para-aortic lymphadenectomy very important part of surgical treatment in this disease.